Latest Cci updates from LegalRepublic.in.
The Competition Commission of India has formed a prima facie opinion of contravention of the Competition Act, 2002 and directed the Director General to investigate Case No. 41 of 2025.
The Competition Commission of India closed a Section 4 complaint against AI video platform InVideo AI, holding that a subscriber's grievance over cancelled paid minutes is a private dispute, not a competition matter.
The Competition Commission found the Director General's comparisons of hospital prices with standalone diagnostic labs and procurement costs inadequate to establish unfair pricing under Section 4.
The Competition Commission found the Director General's methodology flawed on relevant market, pricing comparisons, and dominant position, closing the decade-long Section 4 inquiry.
The Competition Commission finds a prima facie case of exclusive dealing under Section 3(4)(b) against Pernod Ricard and linked wholesalers and retailers in Delhi's IMFL market.
The Competition Commission of India dismissed a complaint alleging predatory pricing and market abuse by ride-hailing platform Rapido, finding the charges unsubstantiated under competition law.
The Competition Commission of India declined interim directions against Venkateshwara Hatcheries and related entities, holding the informant failed to meet the high threshold set by the Supreme Court in the SAIL judgment.
The Competition Commission found the Director General's comparisons of hospital prices with hotel tariffs and standalone diagnostic labs methodologically flawed, closing the Section 4 case against Apollo Hospital.
The Competition Commission of India closed Case No. 77(7) of 2015 against Fortis Flt. Lt. Rajan Dhall Hospital, finding the DG's aftermarket abuse findings unsustainable on evidence.
The Competition Commission of India closed a decade-long inquiry against Max Super Specialty Hospital, Patparganj, finding the Director General's methodology for establishing unfair pricing under Section 4 legally insufficient.
The Competition Commission of India has closed a decade-long inquiry against BLK Max Super Specialty Hospital, finding the DG's evidence insufficient to establish unfair pricing under Section 4 of the Competition Act.
The Competition Commission found the Director General's methodology flawed on room rent, diagnostics, consumables and medicines, and declined to delineate a separate aftermarket for admitted patients.
